Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech NamesBenzinga • 04/20/23
Madrigal (MDGL) Gains on NASH Treatment's Breakthrough Therapy TagZacks Investment Research • 04/19/23
Why Top 1% Biotech Madrigal Pharmaceuticals Just Surged Closer To A BreakoutInvestors Business Daily • 04/18/23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports 2022 Fourth Quarter and Full Year Financial ResultsGlobeNewsWire • 02/23/23
Madrigal Announces Additional Positive Results from the Pivotal Phase 3 MAESTRO-NASH Clinical Trial of Resmetirom for the Treatment of NASH with Liver FibrosisGlobeNewsWire • 01/06/23
Traders who bet against stocks made a killing in 2022, as short sellers netted $300 billionCNBC • 01/06/23
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom ProgramGlobeNewsWire • 12/21/22